Yardstick Research tear-sheet / healthcare RCM cohort

Methodology · how we score · rubric weights in plain sight · vendors received this sheet seven days before publication and could flag factual errors, never rankings

Janus-Health

Identity

• Name: Janus Health (legal entity: Janus Health Technologies, Inc.); product platform JanusIQ launched June 2025
• Founded: 2020 by Brendan Downing (ex-Epic implementer, former founder of Falcon Consulting)
• HQ: Source discrepancy - Chicago, IL per Enhanced Healthcare Partners portfolio + BuiltIn Chicago; Dallas, TX origin on the June 2025 JanusIQ press release and current CEO base. The /contact page lists no physical address.
• Funding: $64M-$74M total raised; largest round $45.1M Series B (March 2023, led by Enhanced Healthcare Partners); most recent $10M Series B-II (October 2024)
• Employees: ~52 per BuiltIn Chicago, likely lower as of research date given Glassdoor-reported layoff cadence
• Leadership: Todd Doze (CEO, appointed May 2024, ex-Alpha II CEO); Chris Ellsberry (CTO, ex-FinThrive); John Garcia (CPO, ex-Revecore); Jamie Hill-Walters (CCO, ex-Alpha II); Clay Hatzenbuhler (CFO, ex-Enhanced Healthcare Partners); Brendan Downing (co-founder + board member, CEO 2020-2024)
• Archetype: Heritage RCM workforce-automation platform with AI features layered on top under the JanusIQ rebrand; Epic-implementation pedigree at the founder and operational level

Total score: 60 / 100

(63 raw weighted - 3 pricing-transparency soft penalty)

• Stage fit:
• Foundation (<40 readiness): no - enterprise sales motion, multi-year contracts, no self-serve pilot; foundation-stage buyers cannot adopt
• Pilot (40-59): conditional - yes if pilot is single-engine (AccessIQ prior-auth only, or AccelerateIQ Teleport claim-status only) at a $50M-$500M regional health system running Epic; no if buyer wants AI-native architecture or HITRUST-mandated procurement
• Scale (60-79): yes - this is the sweet spot. Regional health systems and academic medical centers ($250M-$5B revenue) running Epic that want to reduce manual RCM workload without replacing the underlying RCM platform
• Optimization (80+): conditional - yes if buyer already runs Epic + Availity Essentials Pro and wants overlay automation; no if buyer wants foundation-model-native reasoning or already has competing AI-native RCM in place
• One-line verdict: A credible Epic-overlay workforce-automation choice for regional health systems running on Availity, weakened by no-HITRUST security floor, undisclosed AI architecture, and a severe Glassdoor employee-experience signal that puts customer-team retention at risk.

Headline numbers

Dimension scores

Pricing detail

• Public price anchor: None. /pricing returns 404. The only platform CTA across AccessIQ / AccelerateIQ / AdaptiveIQ is "Request a Demo."
• Inferred model: [ESTIMATED] Multi-year SaaS contracts with implementation fees and likely per-engine modular pricing, consistent with the heritage RCM-software-vendor pattern. No Janus source confirms this structure.
• Minimum contract size: [UNKNOWN]

Integrations

• Epic: Workflow-level integration documented (founder Downing's Epic-implementer pedigree + "faxed-referrals-into-Epic with AI" use case in AccessIQ); no published Epic App Orchard / Showroom listing.
• Availity: Native - Feb 2024 strategic partnership integrates JanusIQ with Availity Essentials Pro for payer-portal connectivity and process-mining recommendations.
• Cerner / Oracle Health: [UNKNOWN] No published native connector or CODE conformance statement.
• Meditech / Athenahealth / NextGen / Allscripts: [UNKNOWN] Not enumerated on any publicly fetched Janus page.
• FHIR / HL7 / SMART on FHIR: [UNKNOWN] No published conformance statement.
• Clearinghouses (Change Healthcare, Waystar, etc.): [UNKNOWN] Not publicly enumerated.

Editorial assessment

Janus Health is a heritage-RCM workforce-automation vendor that has rebranded its product line under "JanusIQ" with an AI overlay since June 2025. The product center of gravity is concrete and well-described: AccessIQ automates prior-authorization, referral-management, and notice-of-admission workflows for Epic shops; AccelerateIQ Teleport navigates payer portals and chases claim status; AdaptiveIQ surfaces operational intelligence dashboards over the workflow layer. Vendor-claimed outcomes (up to 2% revenue yield, 5+ days of cash-flow acceleration, 30% complex-follow-up capacity gain) are corroborated by the March 2023 KLAS Emerging Technology Spotlight where 100% of interviewed customers reported satisfaction and intent to retain. The named-customer roster (CommonSpirit, UCHealth, University of Chicago Medicine, WellStar, Carle Health, Memorial Healthcare System, Tucson Medical Center, Dayton Children's Hospital) is meaningful enterprise validation. For a mid-market regional health system or academic medical center running Epic that wants to extract more yield from existing RCM staff without replacing the underlying RCM platform, Janus is a credible candidate.

The bounded weak spots are clustered and meaningful. First, the AI architecture is not from-day-one. Janus was founded in 2020 around workflow automation; JanusIQ is a 2025 rebrand of that workflow layer with AI features added on top. Founder Downing was an Epic implementer, not an ML researcher, and the executive team's pedigree (FinThrive, TransUnion Healthcare, Alpha II) is heritage RCM rather than AI-native. The product would function recognizably without the AI layer - that is a 50/100 ai_native_score, not the 100 currently recorded in D1. Second, security posture is at the cohort floor, not the cohort norm. SOC 2 Type II + HIPAA on AWS is sufficient to operate, but HITRUST is absent (when peers carry it), no public trust page exists (both /trust and /security return 404), and foundation-model architecture, PHI-training-opt-out, and pen-test cadence are all [UNKNOWN]. Third, the Glassdoor employee-experience signal is severe: 2.9/5 overall rating (25% below the IT-industry average), four rounds of layoffs in the 18 months preceding 2026, three years without raises, two years without bonuses. For a buyer entering a multi-year RCM engagement, account-team retention is a real risk that should be probed explicitly in procurement diligence. Fourth, the funding pattern (large March 2023 Series B, small October 2024 Series B-II extension, no round since) corroborates the layoff signal.

Relative to the cohort: AKASA is the harder-incumbent comparison - also pre-LLM-heritage, also enterprise, but with HITRUST, deeper mid-cycle (coding + CDI) coverage, Cleveland Clinic-tier reference, $205M+ raised. AKASA wins on AI re-platform depth and procurement-grade security; Janus wins on Epic-implementation pedigree and front-end workflow specificity (prior auth + referral management + claim status). Adonis Intelligence is the from-day-one AI-native contrast: more modern architecture, narrower track record. Tennr competes head-on for the AccessIQ "faxed-referrals-into-Epic" use case. Janus's strongest defensible position is the named-customer roster plus the Availity partnership giving a payer-connectivity overlay that AI-native challengers don't yet match.

Revisit if: (1) Janus discloses foundation-model architecture and PHI-training-opt-out default policy, (2) HITRUST CSF certification is achieved, (3) a 2025 KLAS / Black Book equivalent benchmark is published, (4) the Glassdoor layoff-cadence signal resolves or a credible Series C up-round closes, or (5) an Epic App Orchard / Showroom listing appears.

Right-of-reply gaps

The following [UNKNOWN] items should be sent to Janus during the factcheck pipeline:

• Foundation model vendor and architecture - Is the JanusIQ AI built on OpenAI, Anthropic, Google, or proprietary foundation models? What is the model deprecation / version-management posture? (Affects ai_capability_depth + data_compliance_posture)
• PHI training-data opt-out default - Is customer PHI included in or excluded from any model training by default in the standard BAA / DPA? (Affects data_compliance_posture)
• AI safety + hallucination guardrails - What guardrails exist on AI-generated outputs that touch billing? What is the audit log for AI-generated recommendations? (Affects data_compliance_posture)
• HITRUST CSF certification - Is HITRUST in progress, planned, or out of scope? Target date if planned? (Affects data_compliance_posture)
• Public trust / security page - Is a procurement-grade /trust or /security page planned to replace the current 404s? (Affects procurement-friction)
• Pen-test report publication cadence - When was the last pen test? Are reports available under NDA? (Affects data_compliance_posture)
• Data residency - Where in AWS is PHI processed and stored? Multi-region options? (Affects data_compliance_posture)
• Epic App Orchard / Showroom listing - Is Janus listed in the Epic Showroom / App Orchard, or is Epic integration always custom per customer? (Affects workflow_integration_depth)
• Cerner / Oracle Health, Meditech, Athenahealth, Allscripts, NextGen native connectors - Native or per-customer build? (Affects workflow_integration_depth)
• SMART on FHIR conformance - Published conformance statement available? (Affects workflow_integration_depth)
• Minimum contract size / per-claim or per-auth anchor - What is the entry-level deal size? Is pricing per-claim, per-auth, per-FTE, per-encounter, or platform-flat? (Affects pricing_scalability + pricing_transparency)
• Headcount + layoff cadence - Current employee count? How has account-team retention been managed through the layoff rounds reported on Glassdoor? (Risk signal)
• HQ + legal entity address - Chicago or Dallas? Disclosing this on /contact or /about would resolve the third-party-source discrepancy. (Identity)
• Founded-year clarification - 2020 per Tracxn + LinkedIn confirmed?
• Total customer count + segmentation - How many active customers as of 2026? Segmentation by IDN tier? (Affects vendor_strength_evidence)
• 2025 third-party benchmark - Is there a 2025 KLAS, Black Book, or analyst benchmark equivalent to the March 2023 KLAS Spotlight? (Affects vendor_strength_evidence)
• Most recent funding round - Any closed-but-undisclosed round after the October 2024 $10M Series B-II? (Affects vendor_strength_evidence)